A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face
Completed · Phase 1 · Has a placebo group
Conditions studied: Enlarged Pores, Sebum Production
In brief
The purpose of this study is to investigate the efficacy and safety of NT 201 injections in the treatment of enlarged pores and excessive sebum production in the face.
Key facts
- Study ID
- NCT05784363
- Run by
- Merz North America, Inc.
- People needed
- 31
- Starts
- 2022-10-27
- Expected to finish
- 2024-07-31
- Last updated by the study team
- 2024-08-23
Who can join
Age: 21 and older, up to 45. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Cheek pore size assessed as "large" by the investigator
- Oily skin on the forehead
You may not qualify if…
- Treatment with Botulinum toxin (BoNT) of any serotype in the face within the last 12 months
- Facial cosmetic procedure (e.g., chemical peel, photo rejuvenation, mesotherapy, photodynamic therapy, laser treatment, ultrasound treatment, tattooing of eyebrows) within the last 12 months
- Treatment with any dermal filler in the face within the last 12 months
- Any previous insertion of permanent material in the face, including permanent dermal fillers (e.g., silicone, polymethyl methacrylate)
- Any medical condition that may put the subject at increased risk with exposure to botulinum toxin of any serotype
Where it is running
- Merz Investigation Site #0010473 — Los Angeles, California, United States
- Merz Investigation Site #0010101 — Coral Gables, Florida, United States
- Merz Investigation Site #001097 — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.